New guidance for management of aromatase-inhibitor related bone loss in breast cancer
A new Position Statement, jointly published by seven international and European organizations, identifies fracture-related risk factors in patients treated by aromatase-inhibitors (AI) and outlines key management strategies ...
Apr 25, 2017
0
3